Cargando…

Establishment and Characterization of PCL12, a Novel CD5(+) Chronic Lymphocytic Leukaemia Cell Line

Immortalized cell lines representative of chronic lymphocytic leukemia (CLL) can assist in understanding disease pathogenesis and testing new therapeutic agents. At present, very few representative cell lines are available. We here describe the characterization of a new cell line (PCL12) that grew s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agathangelidis, Andreas, Scarfò, Lydia, Barbaglio, Federica, Apollonio, Benedetta, Bertilaccio, Maria Teresa Sabrina, Ranghetti, Pamela, Ponzoni, Maurilio, Leone, Gabriella, De Pascali, Valeria, Pecciarini, Lorenza, Ghia, Paolo, Caligaris-Cappio, Federico, Scielzo, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481539/ https://www.ncbi.nlm.nih.gov/pubmed/26110819 http://dx.doi.org/10.1371/journal.pone.0130195

Ejemplares similares

Correction: Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line
por: Agathangelidis, Andreas, et al.
Publicado: (2015)

Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models
por: Bianco, Mimma, et al.
Publicado: (2016)

PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target
por: Sbrana, Francesca Vittoria, et al.
Publicado: (2023)

Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents
por: Barbaglio, Federica, et al.
Publicado: (2020)

EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine
por: Valsecchi, Roberta, et al.
Publicado: (2020)

Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment
por: Belloni, Daniela, et al.
Publicado: (2018)

3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia Cells
por: Sbrana, Francesca Vittoria, et al.
Publicado: (2021)

Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia
por: McMahon, Kaylin M., et al.
Publicado: (2017)

A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression
por: Farinello, Diego, et al.
Publicado: (2018)

Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial
por: Scarfò, Lydia, et al.
Publicado: (2022)

Ex-Vivo Dynamic 3-D Culture of Human Tissues in the RCCS™ Bioreactor Allows the Study of Multiple Myeloma Biology and Response to Therapy
por: Ferrarini, Marina, et al.
Publicado: (2013)

Correction: Ex-Vivo Dynamic 3-D Culture of Human Tissues in the RCCS™ Bioreactor Allows the Study of Multiple Myeloma Biology and Response to Therapy
por: Ferrarini, Marina, et al.
Publicado: (2013)

Infrequent “chronic lymphocytic leukemia-specific” immunoglobulin stereotypes in aged individuals with or without low-count monoclonal B-cell lymphocytosis
por: Agathangelidis, Andreas, et al.
Publicado: (2021)

3D-STED Super-Resolution Microscopy Reveals Distinct Nanoscale Organization of the Hematopoietic Cell-Specific Lyn Substrate-1 (HS1) in Normal and Leukemic B Cells
por: Sampietro, Marta, et al.
Publicado: (2021)

Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia
por: Minici, Claudia, et al.
Publicado: (2017)

Protocol for generation of 3D bone marrow surrogate microenvironments in a rotary cell culture system
por: Belloni, Daniela, et al.
Publicado: (2022)

High-throughput analysis of the T-cell receptor gene repertoire in low-count monoclonal B-cell lymphocytosis reveals a distinct profile from chronic lymphocytic leukemia
por: Agathangelidis, Andreas, et al.
Publicado: (2020)

Toll-like Receptors in Chronic Lymphocytic Leukemia
por: Muzio, Marta, et al.
Publicado: (2012)

RESCUE OF HIPPO CO-ACTIVATOR YAP1 TRIGGERS DNA DAMAGE-INDUCED APOPTOSIS IN HEMATOLOGICAL CANCERS
por: Cottini, Francesca, et al.
Publicado: (2014)

The Nanomechanical Properties of CLL Cells Are Linked to the Actin Cytoskeleton and Are a Potential Target of BTK Inhibitors
por: Sampietro, Marta, et al.
Publicado: (2023)

P1489: HIGH DOSE IRON IMPAIRS MALIGNANT B-CELL VIABILITY AND IMPROVES IMMUNE ANTITUMOR FUNCTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Bordini, Jessica, et al.
Publicado: (2023)

Modeling the Leukemia Microenviroment In Vitro
por: Scielzo, Cristina, et al.
Publicado: (2020)

Toll-like receptor 9 stimulation can induce IκBζ expression and IgM secretion in chronic lymphocytic leukemia cells
por: Fonte, Eleonora, et al.
Publicado: (2017)

Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia
por: Steurer, Michael, et al.
Publicado: (2019)

Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations
por: Agathangelidis, Andreas, et al.
Publicado: (2018)

Poster: CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022)

CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022)

The effect of a dynamic PCL brace on patellofemoral compartment pressures in PCL-and PCL/PLC-deficient knees
por: Welch, Tyler, et al.
Publicado: (2017)

Computational analysis of the evolutionarily conserved Missing In Metastasis/Metastasis Suppressor 1 gene predicts novel interactions, regulatory regions and transcriptional control
por: Petrov, Petar, et al.
Publicado: (2019)

Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease.
por: Pizzolo, G., et al.
Publicado: (1984)

Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma
por: Ferreri, Andrés J.M., et al.
Publicado: (2022)

Marginal zone lymphoma: Diagnostic challenges among different entities
por: Bongiovanni, Lucia, et al.
Publicado: (2018)

Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma
por: Calcinotto, Arianna, et al.
Publicado: (2015)

Pathogen‐specific B‐cell receptors drive chronic lymphocytic leukemia by light‐chain‐dependent cross‐reaction with autoantigens
por: Jiménez de Oya, Nereida, et al.
Publicado: (2017)

Degradability, cytocompatibility, and osteogenesis of porous scaffolds of nanobredigite and PCL–PEG–PCL composite
por: Hou, Jun, et al.
Publicado: (2016)

PCL Reconstruction Surgery in Third Grade PCL Rupture: A Case Series
por: Albar, Husnul Fuad, et al.
Publicado: (2023)

Establishment of murine myeloid-leukaemia cell line in suspension culture.
por: Preisler, H. D.
Publicado: (1978)

Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles
por: Feng, Runliang, et al.
Publicado: (2012)

The Surgeon’s Role in Relative Success of PCL-Retaining and PCL-Substituting Total Knee Arthroplasty
por: Ritter, Merrill A., et al.
Publicado: (2014)

Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone
por: Alami-Milani, Mitra, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qvnc33s796biilgadjumt5r3b1